Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: KRC stock price vs ALNY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALNY's multiple
Needs ALNY P/E.
Implied fair value · at KRC's multiple
Needs KRC P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: KRC FY 2025 (ended Dec 31, 2025) · ALNY FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 45% equity / 55% debt · EV / Revenue 8.46x · EV / EBITDA 20.44x
Capital structure 90% equity / 10% debt · EV / Revenue 10.25x · EV / EBITDA 63.81x
ALNY carries the larger enterprise value at $38.07B against $9.41B; KRC trades on the lower EV / Revenue multiple (8.46x vs 10.25x); KRC on the lower EV / EBITDA (20.44x vs 63.81x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
KILROY REALTY CORP · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
ALNYLAM PHARMACEUTICALS, INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.97x
5.22x
Net debt / EBITDA
Leverage against operating earnings
11.06x
4.13x
Cash and equivalents
Liquid reserves on the balance sheet
$179.32M
$1.66B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BXP, Inc.
KRC vs BXP
ALEXANDRIA REAL ESTATE EQUITIES, INC.
KRC vs ARE
SL GREEN REALTY CORP
KRC vs SLG
HIGHWOODS PROPERTIES, INC.
KRC vs HIW
Douglas Emmett Inc
KRC vs DEI
Moderna, Inc.
KRC vs MRNA
Sarepta Therapeutics, Inc.
KRC vs SRPT
VERTEX PHARMACEUTICALS INC / MA
KRC vs VRTX
BioNTech SE
KRC vs BNTX
ACADIA PHARMACEUTICALS INC
KRC vs ACAD
$5.27B
$4.12B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
